Cerus (CERS) Gross Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | -65.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 610.00 |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | -359.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 9.00 |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -682.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -682.00 |
| Dec 31, 2025 | 1,152.00 |
| Sep 30, 2025 | 252,167.00 |
| Jun 30, 2025 | -422,285.00 |
| Mar 31, 2025 | 335.00 |
| Dec 31, 2024 | -2,138.00 |
| Sep 30, 2024 | 741,316.00 |
| Jun 30, 2024 | -2,274.00 |
| Mar 31, 2024 | 5,302.00 |
| Dec 31, 2023 | -79.00 |
| Sep 30, 2023 | -999,976.00 |
| Jun 30, 2023 | 301.00 |
| Mar 31, 2023 | 2,455.00 |
| Dec 31, 2022 | 660.00 |
| Sep 30, 2022 | 3,370.00 |
| Jun 30, 2022 | 5,652.00 |
| Mar 31, 2022 | -731.00 |
| Dec 31, 2021 | -398.00 |
| Sep 30, 2021 | 148,647.00 |
| Jun 30, 2021 | -3,751.00 |